(Q44346408)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Benoît Lamarche

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Patrick Couture

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Mathieu Larivière

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Jean-Charles Hogue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Jean Bergeron

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Claude Gagné

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

97-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

A receptor-mediated pathway for cholesterol homeostasis

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Homozygous familial hypercholesterolemia among French Canadians in Québec Province

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25–49 years) versus middle-aged (50–64 years) men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Low-density lipoprotein-independent effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

The role of small, dense low density lipoprotein (LDL): a new look

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effect of fluvastatin on low-density lipoprotein peak particle diameter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Relationship of low-density lipoprotein particle size and measures of adiposity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

LDL size and risk of coronary heart disease in elderly men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Low-density lipoprotein size, pravastatin treatment, and coronary events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900385-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(02)00385-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618273%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference